Quantcast
issue
Read articles, including Science News stories written for ages 9-14, on the SNK website.
Second of two blocked flu papers released
Research names five mutations making potent H5N1 strain airborne
A+ A- Text Size

Research names five mutations making potent H5N1 strain airborne

By Tina Hesman Saey

Web edition: June 21, 2012
Print edition: July 14, 2012; Vol.182 #1 (p. 8)

A controversial research paper banned from publication in 2011 because it contained potentially dangerous information is now available for the world to see.

The study, appearing in the June 22 Science, details experiments in which researchers in the Netherlands created a version of the H5N1 bird flu virus that can be passed through the air from one ferret to another. The H5N1 avian influenza virus currently does not spread between people through coughs or sneezes, but the new work suggests that only a few mutations would be needed to turn H5N1 from a virus that requires close contact into one that could spread through the air.

A U.S. government advisory board originally ruled that the Science paper and a similar one published in the June 21 Nature by researchers from the University of Wisconsin–Madison and Japanese colleagues should not be published in full because terrorists might use information about the flu virus mutations to create a biological weapon (SN: 06/02/12, p. 20). The panel reversed the decision in March after seeing revised versions of both papers and speaking with the scientists.

All the hoopla may have come down to one line in the original version of the Science paper. The potentially offending statement implied that the airborne version of the virus might be as deadly as the original H5N1 strain, which has killed more than half of the people it has infected, says Vincent Racaniello, a virologist at Columbia University who has read both versions of the paper.

The revised version of the paper clearly states that ferrets that caught the airborne version of the virus from other ferrets did not die. “The data are the same, but the way it is explained is very different,” Racaniello says. “Everything is explained and put in context.”

In the study, researchers led by Ron Fouchier of Erasmus Medical Center in the Netherlands performed experiments to determine if the H5N1 virus could mutate into an airborne form capable of spreading among mammals, including humans. The researchers genetically engineered into H5N1 three mutations previously found in other flu viruses that had caused pandemics.

Two of the mutations alter a protein called hemagglutinin on the outside of the virus. Flu viruses invade human and animal cells by using hemagglutinin (the H in H5N1) as a grappling hook to snag proteins that stud the surfaces of the cells. H5N1’s standard version of hemagglutinin grasps proteins found in the bird intestinal tract and in human lungs. The changes the researchers engineered in hemagglutinin have been shown to help the virus grab proteins found in the nose and throat, where the virus could more easily be coughed or sneezed out.

A third mutation in a protein called PB2 helps the virus copy its genetic material more easily at the relatively cool temperatures found in human respiratory tracts.

But those engineered mutations did not allow the virus to spread between ferrets through air, the team found. So the researchers put evolution to work by infecting one ferret, then harvesting viruses from the infected ferret’s sneezes and inoculating a second ferret. Each time the virus reproduces in an infected animal, it may pick up new mutations. After three to four cycles, the virus was already reproducing better than it had before in the ferrets’ upper respiratory tracts, Fouchier says.

After 10 passages the researchers tested the virus’s ability to spread through the air and found that sick ferrets could infect a ferret in a neighboring cage. Fouchier and his colleagues examined the virus’s genes and discovered many mutations. “We show that as little as five mutations and less than 10 are sufficient to make H5N1 virus airborne,” Fouchier says.

Only two mutations (beyond the ones the researchers engineered) were found in all of the airborne viruses, both in the gene for hemagglutinin. One of the mutations, known as H103Y, may make the hemagglutinin protein more stable, Fouchier says. The other mutation, T156A, helps the virus cling more securely to the upper respiratory tract proteins. That mutation is found frequently in nature, including in all human cases of H5N1 infection in Egypt, where the virus is currently active. Egypt has had 168 cases of H5N1 and 60 deaths since 2003, including 10 cases and five deaths so far this year.

Although these changes in hemagglutinin differ from ones found by the Wisconsin group, the mutations may change the protein’s function in similar ways. The virus requires few if any other changes in its other genes to become airborne, Fouchier says.

And since several of the mutations needed to make H5N1 airborne are already found in nature, it is possible that the virus could mutate in a single human host to become a pandemic strain, Derek Smith and Colin Russell of the University of Cambridge and colleagues report in the June 22 Science.
Comment
Print Friendly and PDF

S. Herfst et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science, Vol. 336, June 22, 2012, p. 1534. doi: 10.1126/science.1213362

C.A. Russell et al. The potential for respiratory droplet–transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science, Vol. 336, June 22, 2012, p. 1541. doi: 10.1126/science.1222526


T. Hesman Saey. Designer Flu. Science News Vol. 181, June 2, 2012, p. 20. Available online: [Go to]

T. Hesman Saey. Controversial flu research published. Science News Online May 2, 2012. Available online: [Go to]

T. Hesman Saey. Bird flu less deadly, but more widespread, than official numbers suggest. Science News Vol. 181, March 10, 2012, p. 16. Available online: [Go to]

Comments (2)

Please alert Science News to any inappropriate posts by clicking the REPORT SPAM link within the post. Comments will be reviewed before posting.

  • A Drug Cure will always come too late to save Humanity

    In 1997 the pandemic was stopped in its tracks in Hong Kong. The system adopted was not reliant upon a drug cure but that prevention was better than cure. It worked and Ken Shortridge who devised the strategy was given the Asian equivalent of the Nobel Prize in medicine, The Prince Mahidol Award. By doing this Prof. Shortridge stopped a bird flu pandemic starting and which had the propensity to kill millions (the only one ever to do so and prevent the deaths of incalculable numbers). The premise was, ‘don’t let it start in the first place’.

    Why has the establishment therefore forgotten the first dictum of medical health that ‘prevention is better than cure'?

    And why have those who are advocating a drug cure not taken on-board this system that has worked? This question is postulated because the Swine Flu pandemic showed that with reference to the Spanish Flu in 1918 which took up to 100 million lives, that a cure would come too late. In this respect it was not until 7 months 1 week that a vaccine was created and then it had to be manufactured and thereafter distributed to the masses (a logistics nightmare). In the second wave of the Spanish Flu, after the virus had mutated again into a human-to-human killer, it did its worst between week 16 and week 26, some 1 month 1 week before a cure was found for the Swine Flu pandemic.
    Therefore whatever way we look at it a drug vaccine will come too late to save us, no matter who you are from the president of the United States downwards. Fact not fiction.

    Margaret Chan, Director-General of the WHO says that it is only a matter of time not when the killer virus will emerge - may be next week, next month, next year or whenever; but it will happen sometime and such a pandemic according to pandemic researchers is overdue. Therefore we are living on borrowed time and we have to adopt Prof. Shortridge's strategy for the good of all humanity.

    Dr David Hill
    Chief Executive
    World Innovation Foundation
    david hill david hill
    Jun. 22, 2012 at 1:27pm
  • Greetings, Dr. David Hill! I do not disagree with your notion that prevention is the best measure against a virus, but I'd like to insinuate that the H5N1 virus is only a few mutations away from (literally only 1 or 2 substitution mutations) being transferable by air and contact. The whole point of these experiments were to show what could happen genetically, and expose what we can do to prevent its spread and short-circuit a cure if it were to ever happen. If a geneticist understands the functionality (coded proteins) of a viruses DNA/RNA (or any organism for that matter) it is much easier to manipulate, modify, and or destroy. We're taking the next steps in prevention.
    Nex Nex
    Jun. 24, 2012 at 11:20pm
Registered readers are invited to post a comment. To encourage fruitful discussion, please keep your comments relevant, brief and courteous. Offensive, irrelevant, nonsensical and commercial posts will not be published. (All links will be removed from comments.)

You must register with Science News to add a comment. To log-in click here. To register as a new user, follow this link.

Follow Us